Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Objective: To assess the effect of treatment with MK-0822 5 mg once daily on the risk of developing a first bone metastasis (first disease recurrence) compared to placebo Objective: To assess the effect of treatment with MK-0822 5 mg once daily on disease-free survival compared to placebo Objective: To assess the effect of treatment with MK-0822 5 mg once daily in a subset of 250 patients on lumbar spine, total hip, femoral neck, trochanter and total body bone mineral density (BMD) compared to placebo Objective: To assess the tolerability of treatment with MK-0822 5 mg once daily compared to placebo
Inclusion criteria
- Prevention of disease recurrence in patients with breast cancer